AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

NCT00372736 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

NETWORK

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: AEG35156
DRUG: docetaxel
GENETIC: protein expression analysis
GENETIC: reverse transcriptase-polymerase chain reaction
OTHER: flow cytometry
OTHER: immunoenzyme technique
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis

Sponsor

NCIC Clinical Trials Group